الصفحة الرئيسية>>Signaling Pathways>> Cell Cycle/Checkpoint>> Microtubule/Tubulin>>DCLK1-IN-1

DCLK1-IN-1

رقم الكتالوجGC39486

DCLK1-IN-1 هو توفر حيوي انتقائي عن طريق الفم في مسبار كيميائي متوافق مع الجسم الحي لمجال doublelecortin مثل kinase 1 (DCLK1 kinase)يثبط DCLK1-IN-1 كينازات DCLK1 و DCLK2 (IC50: DCLK1 =9.5 / 57.2 نانومتر و DCLK2 =31/103 نانومتر في اختبار الربط والكيناز ، على التوالي)يُظهر DCLK1-IN-1 سمية منخفضة ، ويمكنه التحقيق في بيولوجيا DCLK1 وإثبات دوره في السرطان ، مثل سرطان الغدة البنكرياس القنوي (PDAC)

Products are for research use only. Not for human use. We do not sell to patients.

DCLK1-IN-1 التركيب الكيميائي

Cas No.: 2222635-15-4

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
228٫00
متوفر
1mg
75٫00
متوفر
5mg
196٫00
متوفر
10mg
315٫00
متوفر
25mg
602٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

DCLK1-IN-1 is a selective, oral bioavailability in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1 kinase) domain. DCLK1-IN-1 inhibits DCLK1 and DCLK2 kinases (IC50: DCLK1=9.5/57.2 nM and DCLK2=31/103 nM in binding and kinase assay, respectively). DCLK1-IN-1 shows low toxicity, and can investigate DCLK1 biology and establish its role in cancer, like DCLK1+ pancreatic ductal adenocarcinoma (PDAC)[1].

[1]. Ferguson FM, et al. Discovery of a selective inhibitor of doublecortin like kinase 1. Nat Chem Biol. 2020 Apr 6.

مراجعات

Review for DCLK1-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DCLK1-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.